# Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women

> **NCT02981459** · PHASE4 · WITHDRAWN · sponsor: **State University of New York at Buffalo**

## Conditions studied

- Urinary Frequency/Urgency
- Bladder Irritable
- Bladder Pain Syndrome

## Interventions

- **DRUG:** Mirabegron

## Key facts

- **NCT ID:** NCT02981459
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-12-08
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn by Sponsor
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02981459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02981459, "Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02981459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*